Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2373041 | 1.00 | CFTR (0.56) | CFTRKDM4EHTTMAPK1LMNA | |
| SCHEMBL14783370 | 0.86 | CFTR (0.57) | CFTRKDM4EHTTNOTUM | |
| SCHEMBL16389694 | 0.84 | AGBL2 (0.50) | CFTRKDM4EMAPK1LMNAALDH1A1 | |
| SCHEMBL30481800 | 0.84 | AGBL2 (0.50) | CFTRKDM4EMAPK1LMNAALDH1A1 | |
| SCHEMBL16456041 | 0.84 | CFTR (0.53) | CFTRKDM4EALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL22208505 | 0.83 | MAPK1 (0.47) | CFTRKDM4EHTTMAPK1LMNA | |
| SCHEMBL15738696 | 0.82 | CFTR (0.57) | CFTRKDM4EHTTLMNAALDH1A1 | |
| SCHEMBL14783371 | 0.82 | CFTR (0.42) | CFTRKDM4EHTTMAPK1ALDH1A1 | |
| SCHEMBL31338969 | 0.81 | MAPK1 (0.59) | KDM4EHTTMAPK1LMNAALDH1A1 | |
| SCHEMBL4125681 | 0.81 | MAPK1 (0.59) | KDM4EHTTMAPK1LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118974058-A | Preparation method and crystalline form of (6A, 12A) -17-amino-12-methyl-6, 15-bis (trifluoromethyl) -13, 19-dioxa-3,4,18-triazatricyclo [12.3.1.12,5] nonadeca-1 (18), 2,4,14,16-pentaen-6-ol | 弗特克斯药品有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-116670140-A | Macrocyclic compounds containing 1,3, 4-oxadiazole rings as modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116171154-A | Modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2023-05-26 | — | — | CN | disclosed |
| EP-3980121-A1 | PYRIDINE AND PYRAZINE DERIVATIVE FOR THE TREATMENT OF CF, COPD, AND BRONCHIECTASIS | Novartis AG (CH) | 2022-04-13 | — | — | EP | disclosed |